Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,154 public trials 551 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Package of Resources for Assisted Contact Tracing: Implementation, Costs, and Effectiveness

NCT05343390

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Balaka District Hospital Balaka, Malawi
  • Balaka OPD Health Centre Balaka, Malawi
  • Chiendausiku Health Centre Balaka, Malawi
  • Kalembo Health Centre Balaka, Malawi
View all 33 locations
View Trial Details
Completed

Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana

NCT04862975

Conditions
Blood-Borne Infections, Breastmilk Fed Infants of Mothers on Select DOI, Communicable Diseases, +13 more
Locations
  • Botswana-UPenn Partnership Botswana, Gaborone, South Africa
  • Lesirane Clinic Botswana, Gaborone, South Africa
  • Mogoditshane Clinic KDC Botswana, Gaborone, South Africa
  • Old Naledi Clinic Botswana, Gaborone, South Africa
View Trial Details
Completed

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

NCT02315703

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Aurora, Colorado, United States
  • Miami, Florida, United States
  • Rockville, Maryland, United States
  • Boston, Massachusetts, United States
View Trial Details
Completed

A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

NCT04129554

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Cliniques Universitaires Saint Luc Brussels, Belgium
  • SGS Belgium NV Edegem, Belgium
  • UZ Antwerpen Edegem, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
View all 41 locations
View Trial Details
Completed

A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

NCT03307915

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection

NCT03982186

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • The Office of Franco Felizarta, MD Bakersfield, California, United States
  • Ruane Clinical Research Group Inc Los Angeles, California, United States
  • Southern California GI and Liver Center San Clemente, California, United States
  • Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 108 locations
View Trial Details
Completed

A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B

NCT03439488

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Republican Clinical Hospital Chisnau, Moldova
  • Auckland Clinical Services Auckland, New Zealand
  • Seoul National University Hospital Seoul, South Korea
  • Severance Hospital, Yonsei University Health System Seoul, South Korea
View Trial Details

Related conditions